IL323948A - תולדות אימידזוטריאזין כמאפנני il-17 - Google Patents
תולדות אימידזוטריאזין כמאפנני il-17Info
- Publication number
- IL323948A IL323948A IL323948A IL32394825A IL323948A IL 323948 A IL323948 A IL 323948A IL 323948 A IL323948 A IL 323948A IL 32394825 A IL32394825 A IL 32394825A IL 323948 A IL323948 A IL 323948A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- compound
- pharmaceutically acceptable
- acceptable salt
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2305585.8A GB202305585D0 (en) | 2023-04-17 | 2023-04-17 | Therapeutic agents |
| PCT/EP2024/060131 WO2024218030A1 (en) | 2023-04-17 | 2024-04-15 | Imidazotriazine derivatives as il-17 modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL323948A true IL323948A (he) | 2025-12-01 |
Family
ID=86497343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL323948A IL323948A (he) | 2023-04-17 | 2025-10-15 | תולדות אימידזוטריאזין כמאפנני il-17 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP4698532A1 (he) |
| JP (1) | JP2026514760A (he) |
| KR (1) | KR20250170130A (he) |
| CN (1) | CN121039130A (he) |
| AR (1) | AR132433A1 (he) |
| AU (1) | AU2024257382A1 (he) |
| CL (1) | CL2025003161A1 (he) |
| CO (1) | CO2025014317A2 (he) |
| GB (1) | GB202305585D0 (he) |
| IL (1) | IL323948A (he) |
| MX (1) | MX2025012309A (he) |
| TW (1) | TW202446365A (he) |
| WO (1) | WO2024218030A1 (he) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2711696C (en) | 2008-01-09 | 2021-10-26 | Reza Dana | Therapeutic compositions for treatment of ocular inflammatory disorders |
| GB201909190D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| AR126255A1 (es) | 2021-07-01 | 2023-10-04 | UCB Biopharma SRL | Derivados de imidazotriazina como moduladores de il-17 |
-
2023
- 2023-04-17 GB GBGB2305585.8A patent/GB202305585D0/en not_active Ceased
-
2024
- 2024-04-15 WO PCT/EP2024/060131 patent/WO2024218030A1/en not_active Ceased
- 2024-04-15 AU AU2024257382A patent/AU2024257382A1/en active Pending
- 2024-04-15 KR KR1020257037867A patent/KR20250170130A/ko active Pending
- 2024-04-15 JP JP2025560251A patent/JP2026514760A/ja active Pending
- 2024-04-15 CN CN202480026312.1A patent/CN121039130A/zh active Pending
- 2024-04-15 AR ARP240100948A patent/AR132433A1/es unknown
- 2024-04-15 EP EP24720077.7A patent/EP4698532A1/en active Pending
- 2024-04-16 TW TW113114099A patent/TW202446365A/zh unknown
-
2025
- 2025-10-15 CO CONC2025/0014317A patent/CO2025014317A2/es unknown
- 2025-10-15 MX MX2025012309A patent/MX2025012309A/es unknown
- 2025-10-15 IL IL323948A patent/IL323948A/he unknown
- 2025-10-15 CL CL2025003161A patent/CL2025003161A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO2025014317A2 (es) | 2025-10-30 |
| EP4698532A1 (en) | 2026-02-25 |
| MX2025012309A (es) | 2025-11-03 |
| JP2026514760A (ja) | 2026-05-13 |
| AU2024257382A1 (en) | 2025-10-09 |
| CN121039130A (zh) | 2025-11-28 |
| AR132433A1 (es) | 2025-06-25 |
| KR20250170130A (ko) | 2025-12-04 |
| CL2025003161A1 (es) | 2025-12-12 |
| GB202305585D0 (en) | 2023-05-31 |
| WO2024218030A1 (en) | 2024-10-24 |
| TW202446365A (zh) | 2024-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7163379B2 (ja) | Ｉｌ－１７調節剤としてのスピロ環インドリン | |
| WO2020120141A1 (en) | Functionalised amine derivatives as il-17 modulators | |
| CN102369200B (zh) | 5元杂环化合物的氮杂螺烷基-烷基氨基甲酸酯衍生物、其制备方法和其治疗用途 | |
| EP4363421A1 (en) | Imidazotriazine derivatives as il-17 modulators | |
| CA3110767A1 (en) | Benzimidazolone derivatives, and analogues thereof, as il-17 modulators | |
| WO2021170631A1 (en) | Difluorocyclohexyl derivatives as il-17 modulators | |
| AU2017201536A1 (en) | Pyrimidinyl Tyrosine Kinase Inhibitors | |
| WO2021170627A1 (en) | Difluorocyclohexyl derivatives as il-17 modulators | |
| WO2022096412A1 (en) | Dicyclopropylmethyl derivatives as il-17 modulators | |
| WO2024126250A1 (en) | Imidazotriazine derivatives as il-17 modulators | |
| WO2022096411A1 (en) | Dicyclopropylmethyl derivatives as il-17 modulators | |
| EP4558223A1 (en) | Imidazotriazine derivatives as il-17 modulators | |
| WO2007053346A1 (en) | Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors | |
| KR20190032534A (ko) | C5a 수용체 길항제로서의 시클릭 펩티드 | |
| WO2024126248A1 (en) | Imidazotriazine derivatives as il-17 modulators | |
| WO2024218030A1 (en) | Imidazotriazine derivatives as il-17 modulators | |
| WO2024126249A1 (en) | Imidazotriazine derivatives as il-17 modulators | |
| WO2024218032A1 (en) | Imidazotriazine derivatives as il-17 modulators | |
| WO2026073937A1 (en) | Imidazotriazine derivatives as il-17 modulators | |
| WO2026073936A1 (en) | Imidazotriazine derivatives as il-17 modulators | |
| JP6757332B2 (ja) | ＲＯＲｃモジュレーターとしてのピリダジン誘導体 | |
| CA3160508A1 (en) | Substituted ((((6-benzylamino-5-fluoropyrimidin-4-yl)amino)methyl)-piperidin-1-yl)acetamide compounds active towards nuclear receptors |